SLC5A2 and colonic neoplasm: Furthermore, SGLT2 is functionally expressed in various cancers including pancreatic, prostate [13], liver [14], and colon cancers [15], and SGLT2 inhibitors (SGLT2-Is) exhibit antitumor effects on these cancers [16].